These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15086387)

  • 1. Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.
    Yoshimasu T; Nishide T; Seo N; Hiroi A; Ohtani T; Uede K; Furukawa F
    Clin Exp Immunol; 2004 May; 136(2):245-54. PubMed ID: 15086387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of spontaneous and drug-induced cutaneous lupus erythematosus.
    Furukawa F; Yoshimasu T
    Autoimmun Rev; 2005 Jul; 4(6):345-50. PubMed ID: 16081025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
    Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
    J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine models of cutaneous involvement in lupus erythematosus.
    Ghoreishi M; Dutz JP
    Autoimmun Rev; 2009 May; 8(6):484-7. PubMed ID: 19239927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of cutaneous lupus erythematosus.
    Angotti C
    Clin Dermatol; 2004; 22(2):105-12. PubMed ID: 15234010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral lesions in lupus erythematosus-cytokines profiles of inflammatory infiltrate.
    Marques ER; Lourenço SV; Lima DM; Nico MM
    J Cutan Pathol; 2010 Apr; 37(4):439-45. PubMed ID: 19751227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus.
    Furukawa F; Tokura Y; Matsushita K; Iwasaki-Inuzuka K; Onagi-Suzuki K; Yagi H; Wakita H; Takigawa M
    J Dermatol; 1996 Oct; 23(10):670-6. PubMed ID: 8973031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr mice.
    Furukawa F; Yoshimasu T; Yamamoto Y; Kanazawa N; Tachibana T
    Autoimmun Rev; 2009 May; 8(6):495-9. PubMed ID: 19162242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.
    Sontheimer RD
    Autoimmun Rev; 2005 Jun; 4(5):253-63. PubMed ID: 15990071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage.
    Vermi W; Lonardi S; Morassi M; Rossini C; Tardanico R; Venturini M; Sala R; Tincani A; Poliani PL; Calzavara-Pinton PG; Cerroni L; Santoro A; Facchetti F
    Immunobiology; 2009; 214(9-10):877-86. PubMed ID: 19625100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
    Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
    Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus.
    Wang D; Drenker M; Eiz-Vesper B; Werfel T; Wittmann M
    Arthritis Rheum; 2008 Oct; 58(10):3205-15. PubMed ID: 18821674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
    Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
    J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistopathology of light-induced skin lesions in lupus erythematosus.
    Velthuis PJ; van Weelden H; van Wichen D; Baart de la Faille H
    Acta Derm Venereol; 1990; 70(2):93-8. PubMed ID: 1969215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
    Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells.
    Janssens AS; Lashley EE; Out-Luiting CJ; Willemze R; Pavel S; de Gruijl FR
    Exp Dermatol; 2005 Feb; 14(2):138-42. PubMed ID: 15679584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of cutaneous lupus erythematosus.
    Kuhn A; Bijl M
    Lupus; 2008 May; 17(5):389-93. PubMed ID: 18490414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinic and pathophysiology of photosensitivity in lupus erythematosus.
    Lehmann P; Homey B
    Autoimmun Rev; 2009 May; 8(6):456-61. PubMed ID: 19167524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.